| 1 |
35150894 | Attenuation of obesity-induced hyperlipidemia reduces tumor growth. | 2022 Apr |
1 |
| 2 |
35524581 | Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation. | 2022 May 7 |
1 |
| 3 |
33168624 | PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport. | 2021 Jan-Jun |
2 |
| 4 |
33591966 | LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability. | 2021 Feb |
1 |
| 5 |
33919597 | Male and Female Animals Respond Differently to High-Fat Diet and Regular Exercise Training in a Mouse Model of Hyperlipidemia. | 2021 Apr 18 |
1 |
| 6 |
34027646 | Diet-induced differential effects on plasma lipids secretion by the inositol-requiring transmembrane kinase/endoribonuclease 1α. | 2021 Apr 30 |
1 |
| 7 |
34186207 | Gut inflammation exacerbates high-fat diet induced steatosis by suppressing VLDL-TG secretion through HNF4α pathway. | 2021 Aug 20 |
4 |
| 8 |
32226531 | Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis. | 2020 |
2 |
| 9 |
33042259 | Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development. | 2020 |
1 |
| 10 |
29329748 | Oral Bifidobacterium longum expressing GLP-2 improves nutrient assimilation and nutritional homeostasis in mice. | 2018 Feb |
1 |
| 11 |
30354205 | Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants. | 2018 Oct |
1 |
| 12 |
26819195 | Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans. | 2016 Jan 27 |
2 |
| 13 |
27599291 | Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosis. | 2016 Oct 3 |
2 |
| 14 |
27655915 | Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression. | 2016 Nov 4 |
1 |
| 15 |
25805502 | Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice. | 2015 May 1 |
1 |
| 16 |
24571057 | Changes in arterial function in a mouse model of human familial hypercholesterolaemia. | 2014 May |
1 |
| 17 |
23749231 | MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. | 2013 Jul |
1 |
| 18 |
24030551 | Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. | 2013 Nov |
2 |
| 19 |
24084845 | Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice. | 2013 Oct 1 |
1 |
| 20 |
22121032 | Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice. | 2012 May |
3 |
| 21 |
22155452 | Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling. | 2012 Feb |
2 |
| 22 |
22616721 | Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice. | 2012 Oct |
1 |
| 23 |
23029362 | Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice. | 2012 |
1 |
| 24 |
23098755 | A malfunction in triglyceride transfer from the intracellular lipid pool to apoB in enterocytes of SOD1-deficient mice. | 2012 Dec 14 |
1 |
| 25 |
21398511 | siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. | 2011 Jun |
2 |
| 26 |
21494143 | Unexpected roles for PCSK9 in lipid metabolism. | 2011 Jun |
1 |
| 27 |
21826528 | ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5). | 2011 Nov |
1 |
| 28 |
19957161 | The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. | 2010 Mar |
1 |
| 29 |
20103594 | Expression of apolipoprotein B in the kidney attenuates renal lipid accumulation. | 2010 Apr 2 |
2 |
| 30 |
20674862 | Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP. | 2010 Aug 4 |
1 |
| 31 |
18056685 | Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice. | 2008 Mar |
2 |
| 32 |
18519977 | ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. | 2008 Sep |
1 |
| 33 |
19026012 | Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins. | 2008 Dec |
2 |
| 34 |
16455790 | A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation. | 2006 Jun |
3 |
| 35 |
16971390 | Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. | 2006 Dec 8 |
1 |
| 36 |
15539551 | Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. | 2005 Feb |
1 |
| 37 |
15790761 | Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation. | 2005 Jul |
4 |
| 38 |
15123680 | The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions. | 2004 Jul 2 |
1 |
| 39 |
15342689 | Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only mice. | 2004 Dec |
8 |
| 40 |
12538880 | Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. | 2003 Feb 4 |
1 |
| 41 |
12615667 | Amino terminal 38.9% of apolipoprotein B-100 is sufficient to support cholesterol-rich lipoprotein production and atherosclerosis. | 2003 Apr 1 |
3 |
| 42 |
12829995 | Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. | 2003 Jul |
6 |
| 43 |
11839763 | Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein. | 2002 Apr 19 |
4 |
| 44 |
11884293 | Hepatic fatty acid synthesis is suppressed in mice with fatty livers due to targeted apolipoprotein B38.9 mutation. | 2002 Mar 1 |
6 |
| 45 |
12015323 | Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. | 2002 Jul 26 |
1 |
| 46 |
12072432 | Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. | 2002 Aug 30 |
5 |
| 47 |
12570165 | Lipoprotein production by the heart: a novel pathway of triglyceride export from cardiomyocytes. | 2002 |
1 |
| 48 |
11598138 | Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. | 2001 Dec 7 |
1 |
| 49 |
11726973 | HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. | 2001 Dec |
1 |
| 50 |
10713055 | A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. | 2000 Mar 17 |
1 |